Literature DB >> 8814161

Gamma knife radiosurgery in 11 hemangioblastomas.

M Niemelä1, Y J Lim, M Söderman, J Jääskeläinen, C Lindquist.   

Abstract

One suprasellar, one mesencephalic, and nine cerebellar hemangioblastomas were treated with the gamma knife in 10 patients (median age 48 years) in Stockholm between 1978 and 1993. Four patients had von Hippel-Lindau disease, a dominant inherited trait predisposing to multiple hemangioblastomas. Six hemangioblastomas were treated with radiotherapy at a median margin dose of 25 Gy (20-35 Gy) before 1990 and the next five with a median of 10 Gy (5-19 Gy). Computerized tomography or magnetic resonance images were available for 10 of the 11 hemangioblastomas at a median follow-up time of 26 months (4-68 months) after radiosurgery. The solid part of six hemangioblastomas shrank in a median of 30 months, whereas four hemangioblastomas were unchanged at a median of 14 months. Five hemangioblastomas had an adjoining cyst and three of these cysts had to be evacuated after radiosurgery. One solitary hemangioblastoma later developed a de novo cyst that also needed evacuation. One patient with two cerebellar hemangioblastomas (margin dose 25 Gy each) developed edema at 6 months and required a shunt and prolonged corticosteroid treatment. The combined follow-up data of the 23 hemangioblastomas in 15 patients from previous literature and the present series indicate that, first, a solitary small- or medium-sized hemangioblastoma usually shrinks or stops growing after radiosurgery. The recommended margin dose is 10 to 15 Gy. Second, the adjoining cyst often does not respond to radiosurgery but requires later, sometimes repeated evacuation.

Entities:  

Mesh:

Year:  1996        PMID: 8814161     DOI: 10.3171/jns.1996.85.4.0591

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  22 in total

1.  Supratentorial hemangioblastoma: clinical features, prognosis, and predictive value of location for von Hippel-Lindau disease.

Authors:  Steven A Mills; Michael C Oh; Martin J Rutkowski; Michael E Sughrue; Igor J Barani; Andrew T Parsa
Journal:  Neuro Oncol       Date:  2012-06-21       Impact factor: 12.300

2.  Neurologic manifestations of von Hippel-Lindau disease.

Authors:  John A Butman; W Marston Linehan; Russell R Lonser
Journal:  JAMA       Date:  2008-09-17       Impact factor: 56.272

3.  Cryptic von Hippel-Lindau disease: germline mutations in patients with haemangioblastoma only.

Authors:  F J Hes; S McKee; M J Taphoorn; P Rehal; R B van Der Luijt; R McMahon; J J van Der Smagt; D Dow; R A Zewald; J Whittaker; C J Lips; F MacDonald; P L Pearson; E R Maher
Journal:  J Med Genet       Date:  2000-12       Impact factor: 6.318

4.  Stereotactic radiosurgery for central nervous system hemangioblastoma: systematic review and meta-analysis.

Authors:  James Pan; Rashad Jabarkheel; Yuhao Huang; Allen Ho; Steven D Chang
Journal:  J Neurooncol       Date:  2017-12-04       Impact factor: 4.130

Review 5.  Central nervous system manifestations in VHL: genetics, pathology and clinical phenotypic features.

Authors:  Sven Gläsker
Journal:  Fam Cancer       Date:  2005       Impact factor: 2.375

6.  Cerebellar hemangioblastoma in a patient with von hippel-lindau disease : a case report.

Authors:  D Abd Hamid; J Abdullah; A Ariff; M Muhamad; M Madhavan
Journal:  Malays J Med Sci       Date:  2000-07

7.  Cerebellar haemangioblastoma: temporising treatment in a high risk pregnancy.

Authors:  Tausif Rehman; Rushna Ali; Howard Yonas
Journal:  BMJ Case Rep       Date:  2009-05-21

8.  Linear accelerator stereotactic radiosurgery can modulate the clinical course of Hemangioblastoma: Case series and review of the literature.

Authors:  Z Zibly; Z R Cohen; A Peled; L Zach; U Nissim; Moshe Attia; Christian Graves; K Camphausen; R Spiegelman
Journal:  J Clin Neurosci       Date:  2020-11-11       Impact factor: 1.961

9.  Solid haemangioblastomas of the CNS: a review of 17 consecutive cases.

Authors:  Jens Rachinger; Rolf Buslei; Julian Prell; Christian Strauss
Journal:  Neurosurg Rev       Date:  2008-09-20       Impact factor: 3.042

10.  Pituitary stalk hemangioblastomas in von Hippel-Lindau disease.

Authors:  Russell R Lonser; John A Butman; Ruwan Kiringoda; Debbie Song; Edward H Oldfield
Journal:  J Neurosurg       Date:  2009-02       Impact factor: 5.115

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.